2-24010167-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001346880.2(MFSD2B):c.71C>A(p.Pro24Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 1,447,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001346880.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MFSD2B | NM_001346880.2 | c.71C>A | p.Pro24Gln | missense_variant | 1/14 | ENST00000338315.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MFSD2B | ENST00000338315.6 | c.71C>A | p.Pro24Gln | missense_variant | 1/14 | 5 | NM_001346880.2 | P2 | |
MFSD2B | ENST00000669179.1 | c.71C>A | p.Pro24Gln | missense_variant | 1/15 | A2 | |||
MFSD2B | ENST00000406420.7 | c.71C>A | p.Pro24Gln | missense_variant | 1/13 | 5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000978 AC: 6AN: 61332Hom.: 0 AF XY: 0.000113 AC XY: 4AN XY: 35386
GnomAD4 exome AF: 0.0000286 AC: 37AN: 1294878Hom.: 0 Cov.: 31 AF XY: 0.0000409 AC XY: 26AN XY: 635688
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.71C>A (p.P24Q) alteration is located in exon 1 (coding exon 1) of the MFSD2B gene. This alteration results from a C to A substitution at nucleotide position 71, causing the proline (P) at amino acid position 24 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at